115 filings
Page 3 of 6
8-K
lfj5e1
14 Nov 13
Results of Operations and Financial Condition
12:00am
8-K
1a1vmx
31 Oct 13
Entry into a Material Definitive Agreement
12:00am
8-K
wsvny5o
2 Oct 13
WaferGen Bio-systems Reports Completion of $15 Million Private Placement Transaction
12:00am
8-K
rq69wya
28 Aug 13
WaferGen Bio-systems Announces New Funding from Private Placement
12:00am
8-K
g8o0bcu1t39uclcw
28 Aug 13
WaferGen Bio-systems Announces Reverse Stock Split and Capital Restructuring
12:00am
8-K
uu4rz3d39dj5p4t80ay6
31 May 13
Submission of Matters to a Vote of Security Holders
12:00am
8-K
i3hua1
9 May 13
WaferGen Launches SmartChip TE – A Novel Target Enrichment Solution for Next-Gen Sequencing (NGS) Aimed at Clinical Applications
12:00am
8-K
2cw7czw2
11 Mar 13
WaferGen Partners with Salk Institute to Establish a Nano-qPCR Core Lab
12:00am
8-K
en84bc3dg8h8nami
19 Feb 13
WaferGen Bio-systems and QIAGEN KK Sign Agreement for Co-Marketing in Japan
12:00am
8-K
reo9mhm6phy8p2ce
28 Jan 13
WaferGen’s MyDesign Open Platform Facilitates Rapid Development of a Proprietary Prostate Cancer
12:00am
8-K
q8c5mxlwg
14 Jan 13
Departure of Directors or Certain Officers
12:00am
8-K
vxroat3aw6fvtr
8 Jan 13
Superior and Uniform Coverage Should Help Facilitate Clinical Applications of NGS
12:00am
8-K
yl32cab8 cmr
9 Nov 12
RUCDR and WaferGen to Jointly Explore a Wide Range of Applications on the SmartChip qPCR Platform
12:00am
8-K
2u7bny
19 Sep 12
WaferGen Bio-systems Awarded 1 Million Euro Grant by the Luxembourg Government to expand
12:00am
8-K
vuznl8byk4d8jd2f
10 Jul 12
Regulation FD Disclosure
12:00am
8-K
rcj43
23 May 12
Departure of Directors or Certain Officers
12:00am
8-K
iwdgf48f3g 84iz
16 Apr 12
WaferGen Bio-systems Announces Open Format qPCR Platform and Strategic Realignment
12:00am
8-K
69lggf4x
28 Mar 12
Departure of Directors or Certain Officers
12:00am
8-K
99n5ken s3iot4yclwu2
9 Mar 12
Departure of Directors or Certain Officers
12:00am
8-K
h5qh4tv
13 Jan 12
Departure of Directors or Certain Officers
12:00am